Correction to: Cancer Chemother Pharmacol (2017) 80:715–721 DOI 10.1007/s00280-017-3405-7
The author would like to correct the errors in the publication of the original article. The corrected details are given below for your reading.
The second sentence of the “Introduction” section should read as:
A majority of these patients will have glioblastoma, the most malignant variant of glioma [1].
Author information
Authors and Affiliations
Corresponding authors
Additional information
The original article can be found online at https://doi.org/10.1007/s00280-017-3405-7.
Rights and permissions
About this article
Cite this article
Badruddoja, M.A., Pazzi, M., Sanan, A. et al. Correction to: Phase II study of bi-weekly temozolomide plus bevacizumab for adult patients with recurrent glioblastoma. Cancer Chemother Pharmacol 81, 223 (2018). https://doi.org/10.1007/s00280-017-3448-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00280-017-3448-9